MORRISVILLE, N.C., June 14, 2022 – Myocardial Solutions, Inc. (MSI) announced the opening of the first MyoStrain Cardio-Oncology Center in Madrid. The Center represents a partnership between MSI and Vithas Group (Vithas), a chain of Spanish hospitals.
Vithas recently acquired the locations of GenesisCare, a global oncology treatment company, within Vithas hospitals. The initial site in Madrid is at La Milagrosa hospital and the program is headed by Dr. David Vivas.
The opportunity is to develop a Cardio-Oncology model for the Vithas hospital system that can be replicated in other sites. The clinical goal is to perform MyoStrain tests on the patient throughout the course of treatment and cardio-protect those patients that may suffer cardiotoxicity from cancer treatment. The hope is that by preserving heart function, cancer survivors will live longer and have a higher quality of life.
By having two disciplines, one treating the cancer and one with oversight for heart complications, a more holistic approach to cancer treatment may improve long term outcomes. Cardio-protecting the heart should not interfere with or interrupt the cancer treatment.
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.
808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100
© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM
Score are among the trademarks of Myocardial Solutions.